Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine

NCT00734175 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Influenza
Virus Diseases

Interventions

BIOLOGICAL: H6N1 Teal HK 97/AA ca recombinant vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]